Clearbridge Investments, LLC Agios Pharmaceuticals, Inc. Transaction History

Clearbridge Investments, LLC

$123 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$29.58 - $49.78 $27.4 Million - $46.1 Million	-925,121 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$41.92 - $58.18 $765,333 - $1.06 Million	-18,257 Reduced 1.94%	925,121 $42.7 Million
Q2 2021 Aug 13, 2021	SELL	$52.06 - $61.27 $2.28 Million - $2.68 Million	-43,810 Reduced 4.44%	943,378 $52 Million
Q1 2021 May 13, 2021	SELL	$44.23 - $57.5 $3,980 - $5,175	-90 Reduced 0.01%	987,188 $51 Million
Q4 2020 Feb 10, 2021	SELL	$33.21 - $46.54 $3.32 Million - $4.65 Million	-100,000 Reduced 9.2%	987,278 $42.8 Million
Q3 2020 Nov 12, 2020	SELL	$33.87 - $55.93 $10,194 - $16,834	-301 Reduced 0.03%	1,087,278 $38.1 Million
Q2 2020 Aug 14, 2020	BUY	$34.45 - $53.48 $6,890 - $10,696	200 Added 0.02%	1,087,579 $58.2 Million
Q1 2020 May 15, 2020	SELL	$31.52 - $53.81 $15,886 - $27,120	-504 Reduced 0.05%	1,087,379 $38.6 Million
Q4 2019 Feb 14, 2020	SELL	$30.08 - $50.59 $5.57 Million - $9.36 Million	-185,022 Reduced 14.54%	1,087,883 $51.7 Million
Q3 2019 Nov 14, 2019	SELL	$32.4 - $49.58 $6.99 Million - $10.7 Million	-215,673 Reduced 14.49%	1,272,905 $41.2 Million
Q2 2019 Aug 14, 2019	SELL	$46.17 - $68.1 $1.2 Million - $1.78 Million	-26,080 Reduced 1.72%	1,488,578 $0
Q1 2019 May 15, 2019	BUY	$45.92 - $67.67 $476,879 - $702,752	10,385 Added 0.69%	1,514,658 $102 Million
Q4 2018 Feb 14, 2019	SELL	$42.73 - $76.53 $102,081 - $182,830	-2,389 Reduced 0.16%	1,504,273 $69.4 Million
Q3 2018 Nov 14, 2018	BUY	$71.67 - $91.95 $1,433 - $1,839	20 Added 0.0%	1,506,662 $116 Million
Q2 2018 Aug 14, 2018	SELL	$73.22 - $99.55 $1.59 Million - $2.17 Million	-21,766 Reduced 1.42%	1,506,642 $127 Million
Q1 2018 May 15, 2018	BUY	$59.83 - $86.53 $598 - $865	10 Added 0.0%	1,528,408 $125 Million
Q4 2017 Feb 14, 2018	SELL	$52.12 - $72.33 $25,903 - $35,948	-497 Reduced 0.03%	1,528,398 $87.4 Million
Q3 2017 Nov 14, 2017	SELL	$54.89 - $67.12 $264,569 - $323,518	-4,820 Reduced 0.31%	1,528,895 $102 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,533,715	1,533,715 $78.9 Million

Others Institutions Holding AGIO

# of Institutions

232

Shares Held

58.1M

Call Options Held

403K

Put Options Held

469K

Farallon Capital Management LLC San Francisco, CA

5.66M
Shares

$190 Million
1.26% of portfolio
Vanguard Group Inc Valley Forge, PA

5.55M
Shares

$186 Million
0.0% of portfolio
Black Rock Inc. New York, NY

4.86M
Shares

$163 Million
0.0% of portfolio
Bellevue Group Ag Kuesnacht, V8

3.74M
Shares

$126 Million
2.8% of portfolio
Price T Rowe Associates Inc Baltimore, MD

2.83M
Shares

$95.2 Million
0.01% of portfolio

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.84B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearbridge Investments, LLC with notifications on news.

Account